520 related articles for article (PubMed ID: 16533812)
21. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
[TBL] [Abstract][Full Text] [Related]
22. A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation.
Hess L; Moos V; Lauber AA; Reiter W; Schuster M; Hartl N; Lackner D; Boenke T; Koren A; Guzzardo PM; Gundacker B; Riegler A; Vician P; Miccolo C; Leiter S; Chandrasekharan MB; Vcelkova T; Tanzer A; Jun JQ; Bradner J; Brosch G; Hartl M; Bock C; Bürckstümmer T; Kubicek S; Chiocca S; Bhaskara S; Seiser C
PLoS Genet; 2022 Aug; 18(8):e1010376. PubMed ID: 35994477
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the Effect of Zebularine in Comparison to and in Combination with Trichostatin A on p21Cip1/Waf1/ Sdi1, p27Kip1, p57Kip2, DNA Methyltransferases and Histone Deacetylases in Colon Cancer LS 180 Cell Line.
Sanaei M; Kavoosi F
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1819-1828. PubMed ID: 32592383
[TBL] [Abstract][Full Text] [Related]
24. Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line.
Waby JS; Chirakkal H; Yu C; Griffiths GJ; Benson RS; Bingle CD; Corfe BM
Mol Cancer; 2010 Oct; 9():275. PubMed ID: 20950428
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma.
Kikuchi J; Wada T; Shimizu R; Izumi T; Akutsu M; Mitsunaga K; Noborio-Hatano K; Nobuyoshi M; Ozawa K; Kano Y; Furukawa Y
Blood; 2010 Jul; 116(3):406-17. PubMed ID: 20351311
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
Chen CQ; Chen CS; Chen JJ; Zhou LP; Xu HL; Jin WW; Wu JB; Gao SM
Mol Cell Biochem; 2013 Nov; 383(1-2):137-48. PubMed ID: 23867991
[TBL] [Abstract][Full Text] [Related]
27. ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line.
Varshochi R; Halim F; Sunters A; Alao JP; Madureira PA; Hart SM; Ali S; Vigushin DM; Coombes RC; Lam EW
J Biol Chem; 2005 Feb; 280(5):3185-96. PubMed ID: 15557281
[TBL] [Abstract][Full Text] [Related]
28. Expression and functional characterization of recombinant human HDAC1 and HDAC3.
Li J; Staver MJ; Curtin ML; Holms JH; Frey RR; Edalji R; Smith R; Michaelides MR; Davidsen SK; Glaser KB
Life Sci; 2004 Apr; 74(22):2693-705. PubMed ID: 15043985
[TBL] [Abstract][Full Text] [Related]
29. CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo.
Buggy JJ; Cao ZA; Bass KE; Verner E; Balasubramanian S; Liu L; Schultz BE; Young PR; Dalrymple SA
Mol Cancer Ther; 2006 May; 5(5):1309-17. PubMed ID: 16731764
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21
Zhou H; Cai Y; Liu D; Li M; Sha Y; Zhang W; Wang K; Gong J; Tang N; Huang A; Xia J
Cell Prolif; 2018 Jun; 51(3):e12447. PubMed ID: 29484736
[TBL] [Abstract][Full Text] [Related]
31. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
32. Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy.
Khabele D; Son DS; Parl AK; Goldberg GL; Augenlicht LH; Mariadason JM; Rice VM
Cancer Biol Ther; 2007 May; 6(5):795-801. PubMed ID: 17387270
[TBL] [Abstract][Full Text] [Related]
33. Histone Deacetylase 3 Regulates Adipocyte Phenotype at Early Stages of Differentiation.
Cricrí D; Coppi L; Pedretti S; Mitro N; Caruso D; De Fabiani E; Crestani M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502211
[TBL] [Abstract][Full Text] [Related]
34. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
Jang YG; Hwang KA; Choi KC
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453545
[TBL] [Abstract][Full Text] [Related]
35. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
Zhang Y; Dufau ML
J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
[TBL] [Abstract][Full Text] [Related]
36. The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.
Zupkovitz G; Grausenburger R; Brunmeir R; Senese S; Tischler J; Jurkin J; Rembold M; Meunier D; Egger G; Lagger S; Chiocca S; Propst F; Weitzer G; Seiser C
Mol Cell Biol; 2010 Mar; 30(5):1171-81. PubMed ID: 20028735
[TBL] [Abstract][Full Text] [Related]
37. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
[TBL] [Abstract][Full Text] [Related]
38. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.
Zhao B; He T
Oncol Rep; 2015 Jan; 33(1):304-10. PubMed ID: 25384499
[TBL] [Abstract][Full Text] [Related]
39. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children.
Lundh M; Christensen DP; Damgaard Nielsen M; Richardson SJ; Dahllöf MS; Skovgaard T; Berthelsen J; Dinarello CA; Stevenazzi A; Mascagni P; Grunnet LG; Morgan NG; Mandrup-Poulsen T
Diabetologia; 2012 Sep; 55(9):2421-31. PubMed ID: 22772764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]